Subtopic Deep Dive

Galectins in Immune Regulation
Research Guide

What is Galectins in Immune Regulation?

Galectins in immune regulation refers to the modulation of T cell apoptosis, dendritic cell function, and cytokine signaling by galectins, particularly galectin-1 and galectin-9, to induce immune tolerance.

Galectins bind β-galactosides on immune cell surfaces to regulate apoptosis and signaling (Perillo et al., 1995; 1063 citations). Galectin-1 induces T cell death, while galectin-9 interacts with Tim-3 to promote exhaustion (Sakuishi et al., 2010; 2010 citations). Over 10 key papers since 1995 detail these mechanisms in tolerance and inflammation (Rabinovich and Toscano, 2009; 885 citations).

Curated Papers

Key Challenges

Why It Matters

Galectin-1 triggers T cell apoptosis via glycosylation-dependent pathways, suppressing anti-tumor responses in cancer (Perillo et al., 1995). Targeting galectin-Tim-3 interactions reverses T cell exhaustion, enhancing immunotherapy efficacy (Sakuishi et al., 2010; Wolf et al., 2019). These interactions inform autoimmune therapies and transplant tolerance by modulating dendritic cell exosomes and cytokine signaling (Théry et al., 2001; van Kooyk and Rabinovich, 2008).

Key Research Challenges

Specificity of galectin-glycan binding

Galectins bind multiple β-galactoside ligands, complicating targeted inhibition in immune cells (Yang et al., 2008). Distinguishing galectin-1 effects on T cells from galectin-9 on Tim-3 remains unresolved (Sakuishi et al., 2010). Over 800 citations highlight isoform-specific challenges (Rabinovich and Toscano, 2009).

Translating tolerance induction clinically

Galectin-mediated T cell apoptosis induces tolerance but risks immunosuppression in cancer (Perillo et al., 1995). Balancing anti-tumor immunity with Tim-3/galectin-9 blockade poses hurdles (Wolf et al., 2019). Dendritic cell exosome modulation adds complexity (Théry et al., 2001).

Quantifying pathway crosstalk

Galectin signaling intersects PD-1 and Tim-3 exhaustion pathways without clear dominance models (Sakuishi et al., 2010). Glycosylation variations alter immune outcomes unpredictably (Reily et al., 2019). Proteomic data from exosomes reveals unmodeled interactions (Théry et al., 2001).

Essential Papers

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

Kaori Sakuishi, Lionel Apétoh, Jenna M. Sullivan et al. · 2010 · The Journal of Experimental Medicine · 2.0K citations

The immune response plays an important role in staving off cancer; however, mechanisms of immunosuppression hinder productive anti-tumor immunity. T cell dysfunction or exhaustion in tumor-bearing ...

Glycosylation in health and disease

Colin Reily, Tyler J. Stewart, Matthew B. Renfrow et al. · 2019 · Nature Reviews Nephrology · 2.0K citations

Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles

Clotilde Théry, Muriel Boussac, P. Véron et al. · 2001 · The Journal of Immunology · 1.5K citations

Abstract Dendritic cells constitutively secrete a population of small (50–90 nm diameter) Ag-presenting vesicles called exosomes. When sensitized with tumor antigenic peptides, dendritic cells prod...

Apoptosis of T cells mediated by galectin-1

Nancy L. Perillo, Karen E. Pace, Jeffrey J. Seilhamer et al. · 1995 · Nature · 1.1K citations

TIM3 comes of age as an inhibitory receptor

Yochai Wolf, Ana C. Anderson, Vijay K. Kuchroo · 2019 · Nature reviews. Immunology · 898 citations

Turning 'sweet' on immunity: galectin–glycan interactions in immune tolerance and inflammation

Gabriel A. Rabinovich, Marta A. Toscano · 2009 · Nature reviews. Immunology · 885 citations

Protein Glycosylation in Cancer

Sean R. Stowell, Tongzhong Ju, Richard D. Cummings · 2015 · Annual Review of Pathology Mechanisms of Disease · 861 citations

Neoplastic transformation results in a wide variety of cellular alterations that impact the growth, survival, and general behavior of affected tissue. Although genetic alterations underpin the deve...

Reading Guide

Foundational Papers

Start with Perillo et al. (1995; 1063 citations) for galectin-1 T cell apoptosis mechanism; Rabinovich and Toscano (2009; 885 citations) for glycan-immune overview; Sakuishi et al. (2010; 2010 citations) for Tim-3 integration.

Recent Advances

Wolf et al. (2019; 898 citations) details Tim-3 maturation; Reily et al. (2019; 2008 citations) covers glycosylation diseases impacting regulation.

Core Methods

Glycan binding assays, Tim-3 blockade, exosome proteomics, and β-galactoside inhibition (Théry et al., 2001; van Kooyk and Rabinovich, 2008).

How PapersFlow Helps You Research Galectins in Immune Regulation

Discover & Search

Research Agent uses citationGraph on Sakuishi et al. (2010; 2010 citations) to map Tim-3/galectin-9 connections, then findSimilarPapers reveals 50+ exhaustion studies. exaSearch queries 'galectin-1 T cell apoptosis pathways' for 200+ OpenAlex hits, filtering >1000-citation papers like Perillo et al. (1995).

Analyze & Verify

Analysis Agent runs readPaperContent on Rabinovich and Toscano (2009) to extract glycan interaction models, then verifyResponse with CoVe cross-checks claims against Théry et al. (2001) exosomes data. runPythonAnalysis processes citation networks with pandas for exhaustion pathway stats; GRADE scores evidence as A-level for galectin-1 apoptosis (Perillo et al., 1995).

Synthesize & Write

Synthesis Agent detects gaps in Tim-3/galectin-9 translation via contradiction flagging across Wolf et al. (2019) and Sakuishi et al. (2010). Writing Agent uses latexEditText for pathway diagrams, latexSyncCitations for 10-paper bibliography, and latexCompile to generate review sections; exportMermaid visualizes galectin-T cell signaling cascades.

Use Cases

"Extract signaling data from galectin-1 T cell apoptosis papers and plot apoptosis rates"

Research Agent → searchPapers 'galectin-1 apoptosis' → Analysis Agent → readPaperContent (Perillo et al., 1995) → runPythonAnalysis (pandas/matplotlib plots rates from 5 papers) → researcher gets CSV of quantified apoptosis metrics.

"Draft LaTeX review on galectin-9 Tim-3 in tolerance with citations"

Synthesis Agent → gap detection on Sakuishi et al. (2010) → Writing Agent → latexEditText (intro/methods) → latexSyncCitations (10 papers) → latexCompile → researcher gets compiled PDF review with figures.

"Find code for galectin glycosylation models from recent papers"

Research Agent → searchPapers 'galectin glycosylation simulation' → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets runnable Python models for glycan binding simulations.

Automated Workflows

Deep Research workflow scans 50+ galectin papers via searchPapers → citationGraph → structured report on immune pathways with GRADE scores. DeepScan applies 7-step CoVe to verify Tim-3/galectin claims across Sakuishi (2010) and Wolf (2019), flagging contradictions. Theorizer generates hypotheses on galectin-1/PD-1 crosstalk from Perillo (1995) and van Kooyk (2008).

Try Doxa for Galectins in Immune Regulation Research

Frequently Asked Questions

What defines galectins in immune regulation?

Galectins modulate T cell apoptosis via galectin-1 binding and Tim-3 exhaustion via galectin-9, inducing tolerance (Perillo et al., 1995; Sakuishi et al., 2010).

What are key methods for studying galectin effects?

Proteomic exosome analysis reveals dendritic cell modulation (Théry et al., 2001); glycan binding assays quantify T cell apoptosis (Rabinovich and Toscano, 2009).

What are the most cited papers?

Sakuishi et al. (2010; 2010 citations) on Tim-3/PD-1; Perillo et al. (1995; 1063 citations) on galectin-1 apoptosis; Rabinovich and Toscano (2009; 885 citations) on glycan tolerance.